Uranium mining industry views on ICRP statement on radon
- PMID: 23089039
- DOI: 10.1016/j.icrp.2012.06.032
Uranium mining industry views on ICRP statement on radon
Abstract
In 2009, the International Commission on Radiological Protection issued a statement on radon which stated that the dose conversion factor for radon progeny would likely double, and the calculation of risk from radon should move to a dosimetric approach, rather than the longstanding epidemiological approach. Through the World Nuclear Association, whose members represent over 90% of the world's uranium production, industry has been examining this issue with a goal of offering expertise and knowledge to assist with the practical implementation of these evolutionary changes to evaluating the risk from radon progeny. Industry supports the continuing use of the most current epidemiological data as a basis for risk calculation, but believes that further examination of these results is needed to better understand the level of conservatism in the potential epidemiological-based risk models. With regard to adoption of the dosimetric approach, industry believes that further work is needed before this is a practical option. In particular, this work should include a clear demonstration of the validation of the dosimetric model which includes how smoking is handled, the establishment of a practical measurement protocol, and the collection of relevant data for modern workplaces. Industry is actively working to address the latter two items.
Copyright © 2012. Published by Elsevier Ltd.
Similar articles
-
Effective dose from inhaled radon and its progeny.Ann ICRP. 2012 Oct-Dec;41(3-4):378-88. doi: 10.1016/j.icrp.2012.06.012. Epub 2012 Aug 22. Ann ICRP. 2012. PMID: 23089037
-
ICRP Publication 115. Lung cancer risk from radon and progeny and statement on radon.Ann ICRP. 2010 Feb;40(1):1-64. doi: 10.1016/j.icrp.2011.08.011. Ann ICRP. 2010. PMID: 22108246 Review.
-
Risk of lung cancer from radon exposure: contribution of recently published studies of uranium miners.Ann ICRP. 2012 Oct-Dec;41(3-4):368-77. doi: 10.1016/j.icrp.2012.06.033. Epub 2012 Sep 12. Ann ICRP. 2012. PMID: 23089036 Review.
-
Dose conversion factors for radon: recent developments.Health Phys. 2010 Oct;99(4):511-6. doi: 10.1097/HP.0b013e3181d6bc19. Health Phys. 2010. PMID: 20838092
-
Radon and the system of radiological protection.Ann ICRP. 2012 Oct-Dec;41(3-4):389-96. doi: 10.1016/j.icrp.2012.06.020. Epub 2012 Aug 22. Ann ICRP. 2012. PMID: 23089038
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical